Heart Test Labs Files 8-K with Corporate Updates
Ticker: HSCSW · Form: 8-K · Filed: Oct 18, 2024 · CIK: 1468492
| Field | Detail |
|---|---|
| Company | Heart Test Laboratories, Inc. (HSCSW) |
| Form Type | 8-K |
| Filed Date | Oct 18, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, financials
TL;DR
Heart Test Labs filed an 8-K on 10/11/24 for corporate updates & financials.
AI Summary
Heart Test Laboratories, Inc. filed an 8-K on October 18, 2024, reporting events as of October 11, 2024. The filing indicates amendments to its Articles of Incorporation or Bylaws and includes financial statements and exhibits. The company is incorporated in Texas and its principal executive offices are located in Southlake, Texas.
Why It Matters
This filing signals potential changes in the company's corporate structure or governance, which could impact its operational framework and shareholder rights.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain immediate negative financial or operational news.
Key Numbers
- 001-41422 — SEC File Number (Identifies the company's filing history with the SEC.)
- 26-1344466 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Heart Test Laboratories, Inc. (company) — Registrant
- Texas (state) — State of Incorporation
- Southlake, Texas (location) — Principal Executive Offices
- October 11, 2024 (date) — Earliest event reported
- October 18, 2024 (date) — Date of Report
FAQ
What specific amendments were made to the Articles of Incorporation or Bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the excerpt. The full filing would need to be reviewed for specifics.
What is the nature of the financial statements and exhibits included in this filing?
The filing states that financial statements and exhibits are included, but the excerpt does not detail their content. These would typically include financial performance data and supporting documents.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on October 11, 2024.
What is the SIC code for Heart Test Laboratories, Inc.?
The Standard Industrial Classification (SIC) code for Heart Test Laboratories, Inc. is 3842, which corresponds to Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Where are Heart Test Laboratories, Inc.'s principal executive offices located?
Heart Test Laboratories, Inc.'s principal executive offices are located at 550 Reserve Street, Suite 360, Southlake, Texas 76092.
Filing Stats: 653 words · 3 min read · ~2 pages · Grade level 11.3 · Accepted 2024-10-18 17:00:08
Filing Documents
- ea021806101-8k_heart.htm (8-K) — 31KB
- ea021806101ex3-1_heart.htm (EX-3.1) — 10KB
- 0001213900-24-088995.txt ( ) — 258KB
- hscs-20241011.xsd (EX-101.SCH) — 3KB
- hscs-20241011_def.xml (EX-101.DEF) — 26KB
- hscs-20241011_lab.xml (EX-101.LAB) — 36KB
- hscs-20241011_pre.xml (EX-101.PRE) — 25KB
- ea021806101-8k_heart_htm.xml (XML) — 5KB
03. Amendments to Articles of Incorporation or Bylaws; Change
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On October 11, 2024, Heart Test Laboratories, Inc. (the "Company") filed a Certificate of Amendment to its Amended and Restated Certificate of Formation (the "Certificate of Amendment") with the Secretary of State of the State of Texas to change its corporate name to HeartSciences Inc. (the "Name Change"). The Name Change was approved by the Company's shareholders at the Company's Annual Meeting of Shareholders initially held on January 17, 2024. The Company is currently awaiting confirmation from the Secretary of State of the State of Texas of the effectiveness of the Name Change on the state level. The Company expects to affect the Name Change in the market as soon as possible after such confirmation and will separately announce the effective date of the Name Change. The Name Change will not affect the Company's ticker symbols (HSCS, HSCSW) or the applicable CUSIP number for the Company's public warrants and outstanding shares of common stock. The Company's public warrants and the outstanding stock certificates for shares of the Company will not be affected by the Name Change and will continue to be valid on their terms and need not be exchanged. Other than the Name Change, there will be no changes to the Company's Amended and Restated Certificate of Formation. A copy of the Certificate of Amendment is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.
01. Financial Statements and
Item 9.01. Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 3.1* Certificate of Amendment to the Amended and Restated Certificate of Formation of the Company. 104* Cover Page Interactive Data File (embedded within the Inline XBRL document). * Filed herewith. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEART TEST LABORATORIES, INC. Date: October 18, 2024 By: /s/ Andrew Simpson Name: Andrew Simpson Title: President, Chief Executive Officer and Chairman of the Board of Directors 2